Neuroprotective Effects of Low-dose Lithium in Individuals at Ultra-high Risk for Psychosis. A Longitudinal MRI/MRS Study

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 570-575

Bentham Science Publishers

Access to resources Recommend Favorite

Glutamate and Psychosis Risk

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-02 ,pp. : 466-478

Bentham Science Publishers

Access to resources Recommend Favorite

Cannabis Use in Patients at Clinical High Risk of Psychosis: Impact on Prodromal Symptoms and Transition to Psychosis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 32, 2012-11 ,pp. : 5036-5044

Bentham Science Publishers

Access to resources Recommend Favorite

Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? - A Systematic Review of Structural and Functional Brain Abnormalities

By  

Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. : 467-481

Bentham Science Publishers

Access to resources Recommend Favorite

Episodic Memory Dysfunction in Individuals at High-Risk of Psychosis: A Systematic Review of Neuropsychological and Neurofunctional Studies

By  

Current Pharmaceutical Design, Vol. 18, Iss. 4, 2012-01 ,pp. : 443-458

Bentham Science Publishers

Access to resources Recommend Favorite